FDA Publishes Annual Report on Postmarketing Requirements and Commitments for Drug and Biologics Firms

Summary

The FDA has released its annual report on postmarketing requirements and commitments for drug and biologics firms, as mandated by the Federal Food, Drug, and Cosmetic Act, providing an update on the status of studies and clinical trials conducted by applicants.